Opus Genetics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2004-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://opusgtx.com
Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD)
Phase 1
Recruiting
- Conditions
- LCA5
- Interventions
- Biological: AAV8.hLCA5
- First Posted Date
- 2022-11-15
- Last Posted Date
- 2024-07-01
- Lead Sponsor
- Opus Genetics, Inc
- Target Recruit Count
- 15
- Registration Number
- NCT05616793
- Locations
- 🇺🇸
University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath